Xolair gets black box labeling
July 05 2007
The FDA has announced new black box labeling for Genentechs Xolair (omalizumab) to address the risk of anaphylaxis in patients ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.